Lifeward Ltd.LFWDEarnings & Financial Report
Nasdaq · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Revenue
$612.0K
Gross Profit
$-3.3M
Operating Profit
$-3.2M
Net Profit
$-3.1M
Gross Margin
-538.6%
Operating Margin
-518.6%
Net Margin
-503.9%
YoY Growth
620.0%
EPS
$-0.35
Lifeward Ltd. Q3 FY2024 Financial Summary
Lifeward Ltd. reported revenue of $612.0K (up 620.0% YoY) for Q3 FY2024, with a net profit of $-3.1M (up 59.0% YoY) (-503.9% margin).
Key Financial Metrics
| Total Revenue | $612.0K |
|---|---|
| Net Profit | $-3.1M |
| Gross Margin | N/A |
| Operating Margin | -518.6% |
| Report Period | Q3 FY2024 |
Lifeward Ltd. Annual Revenue by Year
Lifeward Ltd. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.4M).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.4M |
| 2024 | $1.7M |
| 2023 | $435.0K |
| 2022 | $2.5M |
Lifeward Ltd. Quarterly Revenue & Net Profit History
Lifeward Ltd. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $200.0K | +100.0% | $-5.3M | -2674.0% |
| Q3 FY2025 | $300.0K | -51.0% | $-3.2M | -1056.7% |
| Q2 FY2025 | $400.0K | -19.8% | $-6.6M | -1640.5% |
| Q1 FY2025 | $500.0K | +2.2% | $-4.8M | -966.8% |
| Q4 FY2024 | $100.0K | -31.0% | $-15.3M | -15278.0% |
| Q3 FY2024 | $612.0K | +620.0% | $-3.1M | -503.9% |
| Q2 FY2024 | $499.0K | +548.1% | $-4.3M | -862.5% |
| Q1 FY2024 | $489.0K | +282.0% | $-6.3M | -1283.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $489000 | $499000 | $612000 | $100000 | $500000 | $400000 | $300000 | $200000 |
| YoY Growth | 282.0% | 548.1% | 620.0% | -31.0% | 2.2% | -19.8% | -51.0% | 100.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $55.2M | $51.0M | $45.8M | $30.5M | $28.8M | $26.8M | $23.2M | $22.9M |
| Liabilities | $14.6M | $14.3M | $11.9M | $11.6M | $10.4M | $11.7M | $10.4M | $14.5M |
| Equity | $40.6M | $36.7M | $33.9M | $18.8M | $18.5M | $15.1M | $12.8M | $8.4M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-7.7M | $-5.6M | $-4.5M | $-4.0M | $-5.5M | $-3.9M | $-3.8M | $-3.6M |